Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Bull Exp Biol Med ; 165(6): 746-750, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30353340

ABSTRACT

Oxidative status was assessed in different areas of the cerebral cortex of male Wistar rats under normal condition and during permanent 24-h focal ischemia. In intact animals, the level of lipid hydroperoxides in the frontal lobes of both hemispheres was by 36% higher than in other cortical areas, while total antioxidant activity was by 25% higher than in other areas. During ischemia, changes in oxidative status were localized only in the ischemic focus and penumbra zone and did not involve other cortical areas. We demonstrated for the first time a neuroprotective effect of therapeutic administration of carnosine in low doses (50 mg/kg) on parameters of the oxidative status under conditions of focal ischemia comparable to its effect of high doses (500 mg/kg) as well as its local effect in the penumbra zone. A dose-dependent effect of carnosine on antioxidant activity in the penumbra zone during ischemia was also demonstrated. These findings confirm effectiveness of not only preventive carnosine administration, but also its application in the postischemic period of the stroke.


Subject(s)
Brain Ischemia/physiopathology , Carnosine/pharmacology , Cerebral Cortex/drug effects , Cerebral Cortex/physiology , Oxidative Stress , Animals , Antioxidants/metabolism , Brain Ischemia/metabolism , Ischemia/drug therapy , Male , Neuroprotective Agents/pharmacology , Rats , Rats, Wistar , Stroke/drug therapy
2.
Bull Exp Biol Med ; 164(3): 293-297, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29308569

ABSTRACT

Expression of inducible NO-synthase mRNA and myocardial infiltration with neutrophils were studied in rats with modeled permanent ischemia and ischemia/reperfusion models. Expression of inducible NO synthase mRNA in the ischemic region increased significantly in 3, 3.5, and 4 h in modeled ischemia/reperfusion and in 3.5 and 4 h in permanent ischemia. Myocardial infiltration with neutrophils was significantly higher than in intact controls throughout the experiment without significant intergroup differences. In non-ischemic myocardium, enhanced expression of inducible NO synthase mRNA and moderate neutrophilic-lymphocytic myocardial infiltration were also observed in 3.5, and 4 h after ischemia.


Subject(s)
Lymphocytes/immunology , Myocardial Reperfusion Injury/genetics , Myocardium/enzymology , Neutrophils/immunology , Nitric Oxide Synthase Type II/genetics , RNA, Messenger/genetics , Animals , Animals, Outbred Strains , Cell Movement , Gene Expression Regulation , Lymphocytes/cytology , Male , Myocardial Reperfusion Injury/enzymology , Myocardial Reperfusion Injury/immunology , Myocardial Reperfusion Injury/pathology , Myocardium/immunology , Myocardium/pathology , Neutrophil Infiltration , Neutrophils/cytology , Nitric Oxide Synthase Type II/metabolism , RNA, Messenger/metabolism , Rats , Time Factors
3.
Bull Exp Biol Med ; 163(5): 617-619, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28948544

ABSTRACT

The effect of peptide Semax on remodeling of cardiac sympathetic innervation was examined in rats with experimental myocardial infarction. In 28 days after ischemia/reperfusion injury, Semax diminished the growth of sympathetic innervation of ventricular septum, although it produced no effect on the density of ß1 and ß2 adrenoceptors.


Subject(s)
Myocardial Infarction/metabolism , Prostatitis/metabolism , Adrenocorticotropic Hormone/analogs & derivatives , Adrenocorticotropic Hormone/therapeutic use , Animals , Male , Myocardial Infarction/drug therapy , Peptide Fragments/therapeutic use , Prostate/drug effects , Prostate/metabolism , Prostate/pathology , Prostatitis/drug therapy , Quercetin/analogs & derivatives , Quercetin/therapeutic use , Rats , Rats, Wistar , Sympathetic Nervous System/drug effects , Sympathetic Nervous System/metabolism , Sympathetic Nervous System/pathology
4.
Zh Nevrol Psikhiatr Im S S Korsakova ; 116(8 Pt 2): 17-23, 2016.
Article in Russian | MEDLINE | ID: mdl-27905383

ABSTRACT

AIM: To study a role of ATP-dependent potassium channels (K+ATP) in the neuroprotective effect of ischemic (IP) and pharmacological (PP) preconditioning and evaluate the dynamics of blood nitric oxide (NO) metabolites in cerebral ischemia. MATERIAL AND METHODS: A model of ischemic stroke induced by the electrocoagulation of a middle cerebral artery (MCA) branch was used in male rats (n=86). Glibenclamide, a selective inhibitor of ATP-sensitive K+ channels, and diazoxide, a potassium channel activator, were used. IP and PP were performed 24 h before MCA occlusion. Blood concentrations of NO, NO3- and NO2-were measured 5, 24 and 72 h after occlusion. RESULTS: IP decreased a lesion area by 37% (p<0/05) and the preliminary introduction ofglibenclamide levelled the effect of IP. A protective effect of PP was similar to that of IP. A decrease in oxygenated R-conformers of Hb-NO and a reverse increase in non-oxygenated T-conformers as well as NO3- и NO2-were noted 5h after MCA occlusion. In the first 24 h after MCA occlusion, contents of NO3- and NO2- returned to normal values. There were changes in the concentrations of Hb-NO complexes as well, with the predominance of R-conformers and minimal contents of T-conformers. Moreover, the correlations between K+ATP channel blockade and the decrease in serum NO3- and NO2 were found (p<0/03). CONCLUSION: The neuroprotective effect of preconditioning is caused by the activation of K+ATP channels. An analysis of NO metabolite concentrations in the blood of rats with IP suggests that Hb-NO complexes belonging to R-conformers deposit and carry NO in tissues releasing NO accumulated via R→T transfer in conditions of ischemia.


Subject(s)
Adenosine Triphosphate , Ischemic Preconditioning, Myocardial , Neuroprotective Agents , Potassium Channels , Animals , Diazoxide , Glyburide , Infarction, Middle Cerebral Artery , Male , Neuroprotective Agents/pharmacology , Nitric Oxide/metabolism , Potassium Channels/physiology , Rats
5.
Bull Exp Biol Med ; 161(4): 476-80, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27591879

ABSTRACT

Activation of the sympathetic nervous system aggravates the course of myocardial infarction. Semax peptide moderated the degree of this activation and prevented the increase in the density of sympathetic endings in rat caudal artery in 28 days after ischemia or ischemia/reperfusion. The peptide reduced the density of α-adrenoreceptors in the caudal artery of rats with myocardial infarction. Semax produced no effect on ß-adrenoreceptors in both experimental models. The experiments on isolated segments of the caudal artery revealed reduced vascular responsiveness to electrical stimulation and norepinephrine infusion in rats treated with Semax after ischemia/reperfusion injury.


Subject(s)
Adrenocorticotropic Hormone/analogs & derivatives , Myocardial Infarction/drug therapy , Myocardial Infarction/metabolism , Peptide Fragments/pharmacology , Peptide Fragments/therapeutic use , Sympathetic Nervous System/drug effects , Sympathetic Nervous System/metabolism , Adrenocorticotropic Hormone/pharmacology , Adrenocorticotropic Hormone/therapeutic use , Animals , Electric Stimulation , Male , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Norepinephrine/pharmacology , Norepinephrine/therapeutic use , Rats , Receptors, Adrenergic, beta/metabolism
6.
Ross Fiziol Zh Im I M Sechenova ; 102(9): 1111-9, 2016 Sep.
Article in Russian | MEDLINE | ID: mdl-30193428

ABSTRACT

This study is dedicated to the research of the regulatory peptide PGP and its acetylated form (N-AcPGP) effect on the paw edema formation and vascular permeability in rat skin. Edema was induced by subcutaneous administration of histamine. Vascular permeability was determined by intradermal injection of mast cells activators corticotropin-releasing hormone (CRH), lipopoly-saccharide (LPS), Synacthen (corticotropin analogue), histamine and compound 48/80. We established that PGP reduced the size of the paw edema, but N-AcPGP had an opposite effect increasing paw edema. Skin vascular permeability didn't increase in rats under the administration of PGP or N-AcPGP with additional injections of CRH, LPS and Synacthen, but with additional injections of histamine and substance 48/80. We demonstrated in vitro that pretreatment with both PGP and N-AcPGP reduced histamine secretion by rat's peritoneal mast cells under activation by Synacthen. These results provide evidence that the effect of the peptides on vascular permeability is mainly mediated by the influence on the secretory activity of mast cells.


Subject(s)
Capillary Permeability/drug effects , Oligopeptides , Proline/analogs & derivatives , Skin , Acetylation , Animals , Edema/drug therapy , Edema/metabolism , Histamine/metabolism , Male , Mast Cells/cytology , Mast Cells/metabolism , Oligopeptides/pharmacokinetics , Oligopeptides/pharmacology , Proline/pharmacokinetics , Proline/pharmacology , Rats , Skin/blood supply , Skin/metabolism
7.
Ross Fiziol Zh Im I M Sechenova ; 101(7): 789-803, 2015 Jul.
Article in Russian | MEDLINE | ID: mdl-26591052

ABSTRACT

Monocyte chemotactic protein-1 (MCP-1) is a chemokine that stimulates monocytes and macrophage migration into the sites of acute of chronic inflammation. Our study shows morphological changes in ischemic myocardium followed by the administration of two synthetic structural fragments of MCP-1 that are monocyte/macrophage migration inductor peptide IX and peptide X an inhibitor. Results show that peptides can change time points of the inflammatory response in myocardium. Peptide IX administration leads to increased and accelerated inflammatory response, i. e. attracts an additional number of monocytes and macrophages into the inflammatory focus. The introduction of the peptide X observed prolonged inflammatory process with the overall gain signs of myocardial damage.


Subject(s)
Chemokine CCL2/therapeutic use , Myocardial Reperfusion Injury/drug therapy , Peptide Fragments/therapeutic use , Animals , Chemokine CCL2/pharmacology , Macrophages/drug effects , Male , Monocytes/drug effects , Peptide Fragments/pharmacology , Rats
8.
Klin Med (Mosk) ; 93(7): 14-20, 2015.
Article in Russian | MEDLINE | ID: mdl-26596053

ABSTRACT

This paper focuses on the risk factors of primay and secondary proliferative vitreoretinopathy, modern views of pathophysiology of this disease, and the role of inflammation in its development. Special attention is given to the involvement of pigment epithelial cells, macrophages, hyalocytes, gliocytes, supporting fibers (Muller's cells), mediators of inflammation, such as cytokines, chemokines, and growth factors, with reference to their interaction in the processes of proliferation and development of retinal membranes.


Subject(s)
Inflammation/metabolism , Vitreoretinopathy, Proliferative , Cytokines/blood , Ependymoglial Cells/pathology , Humans , Intercellular Signaling Peptides and Proteins/blood , Retinal Pigment Epithelium/pathology , Vitreoretinopathy, Proliferative/metabolism , Vitreoretinopathy, Proliferative/pathology , Vitreoretinopathy, Proliferative/physiopathology
9.
Ross Fiziol Zh Im I M Sechenova ; 101(5): 572-85, 2015 May.
Article in Russian | MEDLINE | ID: mdl-26263683

ABSTRACT

In this article we review and discuss the advantages of two proliferative vitreoretinopathy models in rats: intravitreal injection of proteolytic enzyme dispase and proinflammatory lectin concanavalin A. For the first time we selected clear morphological criteria for the retina evaluation during the inflammatory response. We also compared the effects of the injection of dispase and concanavalin on the 7th day after the drugs administration. We conclude that different doses of dispase can be used to get a stable model of PVR on different periods after the injection procedure.


Subject(s)
Concanavalin A/toxicity , Endopeptidases/toxicity , Retina/physiopathology , Vitreoretinopathy, Proliferative/physiopathology , Animals , Disease Models, Animal , Humans , Injections, Intraocular , Rats , Retina/drug effects , Vitreoretinopathy, Proliferative/chemically induced
10.
Ross Fiziol Zh Im I M Sechenova ; 101(3): 291-307, 2015 Mar.
Article in Russian | MEDLINE | ID: mdl-26016323

ABSTRACT

This study focuses on researching of heart rate variability (HRV) in rats with autoimmune myocarditis. Intact rats were investigated additionally. It was registered 2-, 5- and 20-min duration ECG from awake animals at rest-conditions and after cooling probe (CP), and then time domain and spectral parameters of HRV were calculated. We shown that 1) after CP decreasing of parasympathetic influence and augmentation of sympathetic influence on heart rate regulation in rats with autoimmune myocarditis was more manifested than in intact rats, 2) in CP with the 5-min ECG interval's duration was more informative for HRV estimation, 3) intracardiac inflammation leads to modification of correlation interconnection between some HRV-parameters, and that may talk about features of heart's chronotropic regulation in rats with autoimmune myocarditis.


Subject(s)
Heart Rate/physiology , Nervous System Autoimmune Disease, Experimental/physiopathology , Rest/physiology , Animals , Male , Rats , Regression Analysis
11.
Bull Exp Biol Med ; 157(4): 530-4, 2014 Aug.
Article in English | MEDLINE | ID: mdl-25110099

ABSTRACT

The effects of activated protein C (APC) on the quantitative parameters of neurons and neuroglia in the perifocal zone of infarction induced in the left hemispheric cortex were studied in two groups of rats. Group 1 animals served as control (control infarction). Group 2 rats were injected with APC (50 µg/kg) in the right lateral cerebral ventricle 3 h after infarction was induced, and after 72 h the infarction size was evaluated and the neurons and neuroglia in the perifocal zone were counted. APC reduced the infarction size 2.5 times in comparison with the control and reduced by 16% the neuronal death in the perifocal zone layer V, causing no appreciable changes in layer III, and did not change the size of neuronal bodies but increased (by 11%) the size of neuronal nuclei in layer III. The protein maintained the sharply increased count of gliocytes in the perifocal zone of infarction and promoted their growth. Hence, APC protected the neurons from death in the ischemic focus by increasing the gliocyte count and stimulating the compensatory reparative processes.


Subject(s)
Brain Ischemia/drug therapy , Neuroglia/drug effects , Neurons/drug effects , Neuroprotective Agents/pharmacology , Protein C/pharmacology , Stroke/drug therapy , Animals , Animals, Outbred Strains , Brain Ischemia/pathology , Cell Count , Cell Death/drug effects , Cerebral Ventricles/pathology , Coronary Occlusion/pathology , Injections, Intraventricular , Male , Middle Cerebral Artery/pathology , Neuroglia/pathology , Neurons/pathology , Protein C/agonists , Rats , Stroke/pathology
12.
Ross Fiziol Zh Im I M Sechenova ; 98(2): 269-82, 2012 Feb.
Article in Russian | MEDLINE | ID: mdl-22650071

ABSTRACT

Myocarditis development was investigated after immunization rats with single subcutaneous injection of cardiac myosin (800 microg/kg) with incomplete Freund's adjuvant (IFA) (M + IFA group). Control group received equal volume of IFA alone or nothing (intact group). On days 4, 14, and 21 after injection, light and electron microscopy of heart sections, morphometric analysis, estimation of proinflammatory cytokines (IL-1p, IL-6, VEGF, TNFa and iNOS) expression were used to evaluate inflammatory response in myocardium. In addition, we estimated cardiac myosin antibody levels in blood serum and nitrite and nitrate levels in blood serum. Our data showed that immunization with cardiac myosin combined with IFA led to inflammatory response in the rat myocardium. Acute inflammation (i.e. lymphocyte infiltration of myocardium and increase of proinflammatory cytokines level) in M + IFA group occurred on 21 days after immunization.


Subject(s)
Autoimmune Diseases/metabolism , Cardiac Myosins/administration & dosage , Freund's Adjuvant/administration & dosage , Inflammation/metabolism , Lipids/administration & dosage , Myocarditis/metabolism , Animals , Apoptosis , Autoimmune Diseases/immunology , Cytokines/blood , Inflammation/immunology , Injections, Subcutaneous , Male , Myocarditis/chemically induced , Myocarditis/pathology , Myocardium/pathology , Myocardium/ultrastructure , Myocytes, Cardiac/pathology , Myocytes, Cardiac/ultrastructure , Nitrates/blood , Nitrites/blood , Rats
13.
Kardiologiia ; 51(3): 31-5, 2011.
Article in Russian | MEDLINE | ID: mdl-21627610

ABSTRACT

10% of patients with acute ST-elevation myocardial infarction (STEMI) treated with reperfusion therapy fail to develop an enzyme rise, but do exhibit transient ECG changes, which are consistent with an aborted myocardial infarction. Following reperfusion by primary PCI in STEMI, oxidative stress and an inflammatory response are induced immediately. Inflammation is a critical component of STEMI. Both COX isoforms are involved in reperfusion and ischemic myocardial injury. To evaluate the effectiveness of lornoxicam - nonselective NSAID, in decrease of myocardial injury during acute ST-elevation myocardial infarction. We analyzed 22 patients with STEMI, 14 of them received 16 mg and 8 mg lornoxicam after 20 min and 8 hours, respectively, after arrival to hospital. 12 f them received alteplase, 10 patients with cardiac pain up to 24 hours from the beginning, did not receive reperfusion therapy. All patients received anticoagulants, antiplatlet therapy, -blockers. The primary end point was all-cause mortality by the day 30 and hospitalization due to congestive heart failure by the 1st year. There was no difference in mortality and heart failure by the 30 day and 1st year respectively, between the patients with STEMI treated with lornoxicam or placebo. Randomized controlled trials are needed to explore potential cardioprotective effects of lornoxicam in patients with acute STEMI.


Subject(s)
Myocardial Infarction/therapy , Myocardial Reperfusion Injury , Myocardial Reperfusion/adverse effects , Piroxicam/analogs & derivatives , Administration, Sublingual , Aged , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Cardiotonic Agents/administration & dosage , Cardiotonic Agents/adverse effects , Drug Evaluation , Electrocardiography , Female , Fibrinolytic Agents/therapeutic use , Follow-Up Studies , Heart Failure/etiology , Heart Failure/prevention & control , Hospital Mortality , Humans , Male , Middle Aged , Monitoring, Physiologic , Myocardial Infarction/diagnosis , Myocardial Infarction/mortality , Myocardial Infarction/physiopathology , Myocardial Reperfusion/methods , Myocardial Reperfusion Injury/diagnosis , Myocardial Reperfusion Injury/etiology , Myocardial Reperfusion Injury/physiopathology , Myocardial Reperfusion Injury/prevention & control , Piroxicam/administration & dosage , Piroxicam/adverse effects , Thrombolytic Therapy , Time Factors , Tissue Plasminogen Activator/therapeutic use , Treatment Outcome
14.
Izv Akad Nauk Ser Biol ; (5): 597-609, 2010.
Article in Russian | MEDLINE | ID: mdl-21077370

ABSTRACT

The development of autoimmune myocarditis in rats after a single hypodermic injection of rat myosin mixed with a complete Freund's adjuvant (CFA) (400 microg/kg in 200 microl) was studied. The rats from the control group were injected with only CFA. The titer of antibodies to myosin, infiltration of lymphocytes into the myocardium, ultrastructural damage of myofibrils, mitochondria, and nuclei of cardiomyocytes were maximally pronounced on days 14-21 after the immunization with myosin, which indicates a peak of the inflammatory reaction. The content of nitrites and nitrates in the blood serum and myocardium of immunized rats were also studied. A certain contribution to the development of the inflammation is made by CFA: in rats injected with only CFA, morphological signs of myocarditis were found, but to a much lesser degree than in the group immunized with myosin.


Subject(s)
Autoimmune Diseases/chemically induced , Cardiac Myosins/administration & dosage , Disease Models, Animal , Freund's Adjuvant/administration & dosage , Myocarditis/chemically induced , Myocardium/ultrastructure , Animals , Autoantibodies/blood , Autoimmune Diseases/blood , Autoimmune Diseases/pathology , Cardiac Myosins/immunology , Data Interpretation, Statistical , Enzyme-Linked Immunosorbent Assay , Freund's Adjuvant/immunology , Male , Myocarditis/blood , Myocarditis/immunology , Myocarditis/pathology , Nitrates/blood , Nitrites/blood , Rats
15.
Kardiologiia ; 48(12): 42-8, 2008.
Article in Russian | MEDLINE | ID: mdl-19076093

ABSTRACT

Activation of inflammation and enzyme cyclooxygenase with formation of proinflammatory prostaglandins is a key element of development of myocardial infarction in patients with acute coronary syndrome. Basing on literature data and own experience we suggested that single intravenous injection of 230 mg/kg of nonselective inhibitor of type 1 and 2 cyclooxygenase lornaxicam in the phase of initialization of inflammation 20 min after onset of ischemia would lead to reduction of myocardial infarction volume in rats in irreversible ischemia and ischemia with subsequent reperfusion. The conducted study allowed to reveal that administration of lornoxicam in recommended for human use dose lowered mortality of animals and increased number of capillaries per one cardiomyocyte in case of irreversible coronary artery occlusion. In ischemia-reperfusion as in irreversible myocardial ischemia lornoxicam reduced volume of necrosis and degree of thinning of left ventricular wall in the region of infarction, and lowered volume of connective tissue in periinfarction zone of the myocardium in remote period.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Myocardial Infarction/prevention & control , Piroxicam/analogs & derivatives , Reperfusion Injury/complications , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Disease Models, Animal , Dose-Response Relationship, Drug , Heart Ventricles/drug effects , Heart Ventricles/pathology , Male , Myocardial Infarction/etiology , Myocardial Infarction/pathology , Piroxicam/administration & dosage , Piroxicam/therapeutic use , Rats , Reperfusion Injury/pathology , Treatment Outcome
16.
Probl Tuberk Bolezn Legk ; (10): 21-5, 2008.
Article in Russian | MEDLINE | ID: mdl-19069187

ABSTRACT

The paper analyzes morphological changes and results of surgical treatment in 515 patients with destructive pulmonary tuberculosis. Two hundred and seventy-four patients underwent mediastinal lymphadenectomy and in 241 patients lung resections or pneumonectomies were not followed by lymphadenectomy or solitary caseous molten lymph nodes were removed during an operation. In disseminated destructive pulmonary tuberculosis, active tuberculosis of intrathoracic lymph nodes (ILN) was found in 97%. The latter's significant signs are an enlarged lymph node of more than 2.0 cm, consolidation, periadenitis, and fluctuation. The incidence, extent, and pattern of ILN lesion varied in a lung tuberculous process depending on its site, form, and inflammation phase.


Subject(s)
Lung/pathology , Lymph Node Excision/methods , Lymph Nodes/pathology , Pneumonectomy/methods , Tuberculosis, Pulmonary/surgery , Adolescent , Adult , Humans , Lung/surgery , Lymph Nodes/surgery , Mediastinum , Middle Aged , Retrospective Studies , Severity of Illness Index , Tuberculosis, Pulmonary/pathology , Young Adult
17.
Ross Fiziol Zh Im I M Sechenova ; 94(2): 198-205, 2008 Feb.
Article in Russian | MEDLINE | ID: mdl-18516851

ABSTRACT

Addition of N-acetylcysteine induced relaxation of the coronary and basilar arteries thus indicating some basilar NO-stores in these vessels. The maximum capacity of the NO-stores was similar in the coronary and the basilar arteries. Following adaptation to hypoxia, however, the depot was much greater in the coronary artery wall. This seems to be connected with different degree of participation of the NO-dependent vasodiatation in implementation of the adaptive response to hypoxia in coronary and cerebral vascular systems.


Subject(s)
Adaptation, Physiological , Basilar Artery/metabolism , Coronary Vessels/metabolism , Hypoxia/physiopathology , Nitric Oxide/metabolism , Vasoconstriction/physiology , Acetylcysteine/pharmacology , Animals , Basilar Artery/drug effects , Basilar Artery/physiology , Coronary Vessels/drug effects , Coronary Vessels/physiology , Hypoxia/metabolism , Male , Nitric Oxide Synthase/antagonists & inhibitors , Nitroarginine/pharmacology , Organ Specificity , Rats , Rats, Wistar , Serotonin/pharmacology , Vasoconstriction/drug effects
19.
Eksp Klin Farmakol ; 69(4): 16-8, 2006.
Article in Russian | MEDLINE | ID: mdl-16995431

ABSTRACT

The influence of noopept (N-phenylacetyl-L-prolylglycine ethyl ester, GVS-111) on the extent of ischemic cortical stroke was investigated in experiments on white mongrel male rats with ischemia induced by a combination of the middle cerebral artery occlusion with ipsilateral common carotid artery ligation. Animals were treated with noopept (0.5 mg/kg, i.p.) according to the following schedule: 15 min and 2, 24, and 48 h after the occlusion. Test rats were decapitated 72 h after occlusion, brains were extracted and frozen, and thin brain slices were stained with 2,3,5-triphenyltetrazolium chloride. The slices were scanned and processed using Auc 1 computer program, which estimates the percentage of damaged area relative to that of the whole ipsilateral hemisphere. The conditions of coagulation the distal segment of middle cerebral artery were selected, which caused necrosis localized in the fronto-parietal and dorso-lateral regions of the brain cortex without any damage of subcortical structures. The extent of the brain damage in control group (treated by saline) was 18.6%, while that in the group treated with noopept was 12.2%, thus demonstrating a decrease in the infarction area by 34.5% (p < 05). The data on noopept efficacy on the model of the extensive ischemic injury of brain cortex show that this drug has good prospects for use in the neuroprotective treatment of stroke.


Subject(s)
Brain Ischemia/drug therapy , Dipeptides/therapeutic use , Infarction, Middle Cerebral Artery/complications , Neuroprotective Agents/therapeutic use , Animals , Brain/drug effects , Brain/pathology , Brain Ischemia/etiology , Brain Ischemia/pathology , Carotid Artery, Common , Carotid Stenosis/complications , Cerebral Infarction/drug therapy , Cerebral Infarction/pathology , Ligation , Male , Rats
20.
Ross Fiziol Zh Im I M Sechenova ; 92(6): 732-45, 2006 Jun.
Article in Russian | MEDLINE | ID: mdl-16967870

ABSTRACT

Semax, a member of ACTH-derived peptides family, has been employed in the treatment of acute ischemic stroke in patients. It decreased neurological deficit and reduced NO hyperproduction in the rat brain, caused by acute cerebral hypoperfusion. We suggested that semax is also able to protect rat heart from ischemic damage in acute myocardial infaction (AMI). AMI was induced by left coronary artery occlusion, myocardial ischemic area averaged 30 % of left ventricle. In 2 hours after coronary occlusion, the AMI group developed 11 % reduced mean arterial blood pressure and 48 % increased diastolic blood pressure in left ventricle in comparison with sham-operated control group. However, infusion of either dobutamine, which directly stimulates myocardial contractility, or sodium nitroprusside and phenylephrine, that change vascular resistance and thus cardiac afterload, did not reveal distinctions in hemodynamic parameters between groups. These data indicate absense or only moderate cardiac dysfunction in rats with AMI and are consistent wih morphometrical and histochemical studies that did not detect any necrotic or apoptotic (TUNEL-test) changes in left ventricular cardiomyocytes in spite of development of distinct ischemic disturbances of mitochondria and nuclear in about 50 % of cardiomyocytes in 2 hours after AMI. Semax (150 microg/kg), given i. p. 15 min and 2 hours after coronary occlusion, caused no effect on cardiac function, but completely prevented ischemia-induced ultrastructural changes of cardiomyocytes. This protective effect was accompanied by the ability of peptide to blunt the increase in plasma concentrations of nitrates, observed in AMI group.


Subject(s)
Adrenocorticotropic Hormone/analogs & derivatives , Myocardial Infarction/drug therapy , Peptide Fragments/therapeutic use , Protective Agents/therapeutic use , Adrenocorticotropic Hormone/therapeutic use , Animals , Cardiotonic Agents/pharmacology , Dobutamine/pharmacology , Heart/drug effects , Heart Ventricles/drug effects , Heart Ventricles/ultrastructure , Male , Myocardial Contraction , Myocardial Infarction/pathology , Myocardium/ultrastructure , Nitrates/blood , Nitric Oxide/antagonists & inhibitors , Nitroprusside/pharmacology , Phenylephrine/pharmacology , Rats , Rats, Inbred Strains
SELECTION OF CITATIONS
SEARCH DETAIL
...